Documents | Topotecan for the treatment of recurrent and stage IVB cervical cancer | Guidance | NICE

Documents

A list of downloadable documents created during development.

Background information

TA183 Cervical cancer (recurrent) - topotecan: review decision - December 2012 information
Appendix A: decision paper presented to the Institute's Guidance Executive 03 December 2012 56.51 KB
Cervical cancer (recurrent) - topotecan: review proposal - September 2012 information
Appendix A: provisional matrix of stakeholders 10 September 2012 63.58 KB
Appendix B: proposal paper presented to the Institute's Guidance Executive 10 September 2012 343.5 KB

Cervical cancer (recurrent) - topotecan: final appraisal determination

Cervical cancer (recurrent) - topotecan: final appraisal determination information
Cervical cancer (recurrent) - topotecan: final appraisal determination 10 September 2009 141.35 KB
Response to consultee and commentator comments on the appraisal consultation document 10 September 2009 110.47 KB
Consultee and commentator comments on the ACD
Department of Health 10 September 2009 7.93 KB
Royal College of Nursing 10 September 2009 20.88 KB
GlaxoSmithKline 10 September 2009 278.38 KB

Cervical cancer (recurrent) - topotecan: appraisal consultation

Cervical cancer (recurrent) - topotecan: appraisal consultation
Cervical cancer (recurrent) - topotecan: appraisal consultations document information
Cervical cancer (recurrent) - topotecan: evaluation report
Pre-meeting briefing 17 June 2009 186.17 KB
Cervical cancer (recurrent) - topotecan: evidence review group report 17 June 2009 875.03 KB
NICE clarification letter 17 June 2009 473.85 KB
Royal College of Nursing 17 June 2009 31.21 KB
Manufacturer submissions
Manufacturer response to clarification letter 17 June 2009 394.85 KB
GlaxoSmithKline 17 June 2009 1.21 MB
Expert written personal statements
Oakley 17 June 2009 46.64 KB
Pendleton 17 June 2009 34.12 KB
Symonds 17 June 2009 66.52 KB
Hirschowitz 17 June 2009 34.85 KB

Cervical cancer (recurrent) - topotecan: table of comments on draft scope

Cervical cancer (recurrent) - topotecan: table of comments on draft scope 09 December 2008 79.56 KB

Cervical cancer (recurrent) - topotecan: table of comments on draft matrix

Cervical cancer (recurrent) - topotecan: table of comments on draft matrix 09 December 2008 18.69 KB

Cervical cancer (recurrent) - topotecan: matrix

Cervical cancer (recurrent) - topotecan: matrix 25 August 2009 32 KB

Cervical cancer (recurrent) - topotecan: scope

Cervical cancer (recurrent) - topotecan: scope 04 December 2008 26.91 KB